NO882799L - Heterocykliske forbindelser. - Google Patents

Heterocykliske forbindelser.

Info

Publication number: NO882799L
Authority: NO; Norway
Prior art keywords: heterocyclic compounds; heterocyclic; compounds
Prior art date: 1987-06-24

Application number

NO88882799A

Other languages

English (en)

Other versions

NO882799D0 (no

NO174051B (no

NO174051C (no

Inventor

Klaus Peter Boegesoe

Klaus Gundertofte Jensen

Ejner Knud Moltzen

Henrik Pedersen

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-24

Filing date

1988-06-23

Publication date

1988-12-27

1988-06-23 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

1988-06-23 Publication of NO882799D0 publication Critical patent/NO882799D0/no

1988-12-27 Publication of NO882799L publication Critical patent/NO882799L/no

1993-11-29 Publication of NO174051B publication Critical patent/NO174051B/no

1994-03-09 Publication of NO174051C publication Critical patent/NO174051C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO882799A 1987-06-24 1988-06-23 Analogifremgangsmåte ved fremstilling av terapeutisk aktive tetrazolyl-, triazolyl- og pyrazolylforbindelser NO174051C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB878714789A GB8714789D0 (en)	1987-06-24	1987-06-24	Heterocyclic compounds

Publications (4)

Publication Number	Publication Date
NO882799D0 NO882799D0 (no)	1988-06-23
NO882799L true NO882799L (no)	1988-12-27
NO174051B NO174051B (no)	1993-11-29
NO174051C NO174051C (no)	1994-03-09

Family

ID=10619472

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO882799A NO174051C (no)	1987-06-24	1988-06-23	Analogifremgangsmåte ved fremstilling av terapeutisk aktive tetrazolyl-, triazolyl- og pyrazolylforbindelser

Country Status (19)

Country	Link
US (3)	US4866077A (no)
EP (1)	EP0296721B1 (no)
JP (1)	JP2703268B2 (no)
AU (1)	AU615917B2 (no)
BR (1)	BR1100658A (no)
CA (1)	CA1340458C (no)
DE (1)	DE3881970T2 (no)
DK (1)	DK168600B1 (no)
ES (1)	ES2056928T3 (no)
FI (1)	FI93356C (no)
GB (1)	GB8714789D0 (no)
HK (1)	HK84194A (no)
HU (1)	HU210809A9 (no)
IE (1)	IE61694B1 (no)
IL (1)	IL86618A (no)
NO (1)	NO174051C (no)
NZ (1)	NZ224868A (no)
PT (1)	PT87820B (no)
ZA (1)	ZA884339B (no)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2053748T3 (es) *	1987-09-10	1994-08-01	Merck Sharp & Dohme	Oxazoles y tiazoles para el tratamiento de la demencia senil.
IL88156A (en) *	1987-11-13	1997-02-18	Novo Nordisk As	Azacyclic compounds their preparation and pharmaceutical compositions containing them
ATE87918T1 (de) *	1988-02-19	1993-04-15	Lilly Co Eli	Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren.
DK162892C (da) *	1988-07-04	1992-05-11	Novo Nordisk As	1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
IT1229491B (it) *	1988-12-28	1991-09-03	Roussel Maestretti S P A Ora R	Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
JP3003148B2 (ja) *	1989-01-05	2000-01-24	藤沢薬品工業株式会社	チアゾール化合物、その製造法およびそれを含有する医薬組成物
US4902695A (en) *	1989-02-13	1990-02-20	Eli Lilly And Company	Excitatory amino acid receptor antagonists
US5043345A (en) *	1989-02-22	1991-08-27	Novo Nordisk A/S	Piperidine compounds and their preparation and use
US5260311A (en) *	1989-02-22	1993-11-09	Novo Nordisk A/S	Piperidine compounds and their use
US5328925A (en) *	1989-02-22	1994-07-12	Novo Nordisk A/S	Piperidine compounds and their use
US5264444A (en) *	1989-02-22	1993-11-23	Novo Nordisk A/S	Piperidine compounds and use
EP0402056A3 (en) *	1989-06-06	1991-09-04	Beecham Group p.l.c.	Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
EP0427390B1 (en) *	1989-10-07	1996-03-27	Beecham Group Plc	Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them
US5200419A (en) *	1990-05-21	1993-04-06	Warner-Lambert Company	Substituted tetrazoles and derivatives thereof acting at muscarinic receptors
IE911994A1 (en) *	1990-07-03	1992-01-15	Akzo Nv	5-isothiazolamine derivatives
US5418240A (en) *	1990-08-21	1995-05-23	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
DK198490D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198590D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
USRE35822E (en) *	1990-08-21	1998-06-09	Novo Nordisk A/S	Heterocyclic compounds
US5376668A (en) *	1990-08-21	1994-12-27	Novo Nordisk A/S	Heterocyclic compounds
DK198390D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
US5527813A (en) *	1990-08-21	1996-06-18	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
ES2113939T3 (es) *	1990-11-29	1998-05-16	Allergan Inc	Uso de derivados de piridina en el tratamiento de la hipertension ocular.
WO1992016239A1 (en) *	1991-03-13	1992-10-01	The Regents Of The University Of Minnesota	Radiopharmaceutical agents for the detection of alzheimer's disease
IE922270A1 (en) *	1991-07-26	1993-01-27	Akzo Nv	Pyrazole derivatives
US5641791A (en) *	1991-08-13	1997-06-24	Novo Nordisk A.S	Heterocyclic compounds and their preparation and use
US5175166A (en) *	1991-08-27	1992-12-29	The University Of Toledo	Muscarinic agonists
WO1993014089A1 (en) *	1992-01-13	1993-07-22	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
US5330994A (en) *	1992-03-24	1994-07-19	Warner-Lambert Company	Tetrahydropyridine isoxazoline derivatives
DE69325662T2 (de) *	1992-10-23	2000-02-10	Merck Sharp & Dohme Ltd., Hoddesdon	Dopamin rezeptor subtyp liganden
US5753683A (en) *	1993-08-19	1998-05-19	Novo Nordisk A/S	Antipsychotic method
US5612351A (en) *	1994-11-08	1997-03-18	Novo Nordisk A/S	Method of treating urinary bladder dysfunctions
US5668148A (en) *	1995-04-20	1997-09-16	Merck & Co., Inc.	Alpha1a adrenergic receptor antagonists
JPH11508539A (ja) *	1995-06-29	1999-07-27	ノボノルディスクアクティーゼルスカブ	新規の置換アザ環式化合物
PL326490A1 (en) *	1995-11-06	1998-09-28	Lundbeck & Co As H	Treatment of traumatic brain injuries
AU2568597A (en) *	1996-04-24	1997-11-12	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
US5733912A (en) *	1997-02-19	1998-03-31	Abbott Laboratories	7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
US6297262B1 (en)	1997-05-29	2001-10-02	H. Lundbeck A/S	Treatment of schizophrenia and psychosis
AR013096A1 (es) *	1997-07-01	2000-12-13	Lundbeck & Co As H	Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
JP2001518503A (ja) *	1997-10-02	2001-10-16	ハー・ルンドベック・アクチエゼルスカベット	５−（２−エチル−２ｈ−テトラゾール−５−イル）−１−メチル−１，２，３，６−テトラヒドロピリジンの粒状調合物
CN1315830A (zh) *	1998-07-27	2001-10-03	伊莱利利公司	焦虑疾病的治疗方法
AR025353A1 (es) *	1999-08-23	2002-11-20	Lundbeck & Co As H	Tratamiento de la incontinencia urinaria
EP1274424A4 (en) *	2000-04-12	2003-09-17	Smithkline Beecham Corp	CONNECTIONS AND PROCEDURE
PL365441A1 (en) *	2001-04-05	2005-01-10	Torrent Pharmaceuticals Ltd.	Heterocyclic compounds for aging-related and diabetic vascular complications
US20030069597A1 (en) *	2001-10-10	2003-04-10	Scimed Life Systems, Inc.	Loading tool
HRP20040550A2 (en)	2001-11-19	2006-11-30	Elan Pharmaceuticals	3,4-disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines and piperazines
US7365082B2 (en)	2002-12-18	2008-04-29	Bayer Cropscience Ag	N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
JP2006516140A (ja) *	2002-12-20	2006-06-22	メルク　エンド　カムパニー　インコーポレーテッド	有糸分裂キネシン阻害剤
CA2556589A1 (en) *	2004-02-24	2005-09-01	Bioaxone Therapeutique Inc.	4-substituted piperidine derivatives
US20060224175A1 (en) *	2005-03-29	2006-10-05	Vrba Anthony C	Methods and apparatuses for disposition of a medical device onto an elongate medical device
EP1928437A2 (en) *	2005-08-26	2008-06-11	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation
EP2258359A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009512711A (ja)	2005-10-21	2009-03-26	ブレインセルス，インコーポレイティド	Ｐｄｅ阻害による神経新生の調節
WO2007053596A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenesis by modulating angiotensin
EP2026813A2 (en)	2006-05-09	2009-02-25	Braincells, Inc.	5 ht receptor mediated neurogenesis
WO2008030651A1 (en)	2006-09-08	2008-03-13	Braincells, Inc.	Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
RU2446166C2 (ru) *	2007-04-24	2012-03-27	Солвей Фармасьютикалс Б.В.	Гетероциклические соединения, имеющие сродство к мускариновым рецепторам
US8084473B2 (en)	2007-04-24	2011-12-27	Solvay Pharmaceuticals B.V.	Heterocyclic compounds with affinity to muscarinic receptors
US20110294835A1 (en)	2008-05-15	2011-12-01	The Board Of Trustees Of The University Of Illinois	Muscarinic Agonists as Cognitive Enhancers
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
KR20120018185A (ko) *	2009-05-07	2012-02-29	토렌트 파마슈티칼스 리미티드	당뇨병 치료에 유용한 피페리딘 유도체
BR112013000925A2 (pt)	2010-07-15	2020-12-01	Bayer Intellectual Property Gmbh	compostos heterocíclicos como pesticidas
BR112013009823A2 (pt)	2010-10-22	2016-07-05	Bayer Ip Gmbh	novos compostos heterocíclicos como pesticidas
US9549928B2 (en)	2011-04-29	2017-01-24	The University Of Toledo	Muscarinic agonists as enhancers of cognitive flexibility
CN103848850B (zh) *	2013-08-28	2016-03-23	沈阳东瑞精细化工有限公司	一种舒巴坦的制备方法
US10106525B2 (en)	2015-01-26	2018-10-23	BioAxone BioSciences, Inc.	Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US10857157B2 (en)	2015-01-26	2020-12-08	BioAxone BioSciences, Inc.	Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10149856B2 (en)	2015-01-26	2018-12-11	BioAxone BioSciences, Inc.	Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US11198680B2 (en)	2016-12-21	2021-12-14	BioAxone BioSciences, Inc.	Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
WO2019014322A1 (en)	2017-07-11	2019-01-17	BioAxone BioSciences, Inc.	KINASE INHIBITORS FOR THE TREATMENT OF DISEASES
WO2022067165A1 (en) *	2020-09-28	2022-03-31	Yale University	Selective agonists of 5-ht2a receptor and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2659739A (en)	1950-04-14	1953-11-17	Eastman Kodak Co	1-hydroxy-4-beta-cyanopropylamino-anthraquinone and process for preparing same
BE845612A (fr) *	1976-03-23	1977-02-28		Derives de tetrazole-5-carboxamide et leur preparation
US4431653A (en) *	1982-03-18	1984-02-14	Hoffmann-La Roche Inc.	Penicillanic acid derivatives
DE3421072A1 (de) *	1984-06-06	1985-12-12	Heinrich Mack Nachf., 7918 Illertissen	1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4650805A (en) *	1985-12-02	1987-03-17	Warner-Lambert Company	4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
NZ219646A (en) *	1986-03-27	1990-10-26	Merck Sharp & Dohme	Oxadiazole derivatives of azacyclics for treating cns disorders
GB8610432D0 (en) *	1986-04-29	1986-06-04	Akzo Nv	Amino-thiazole & oxazole derivatives
IL83275A (en) *	1986-09-08	1994-02-27	Novo Nordisk As	Substituted 1, 2, 4- oxadiazolyl piperidine compounds, their preparation and pharmaceutical compositions containing them
IL88156A (en) *	1987-11-13	1997-02-18	Novo Nordisk As	Azacyclic compounds their preparation and pharmaceutical compositions containing them
EP0372125A1 (en) *	1988-11-08	1990-06-13	Akzo N.V.	Oxazole and thiazole derivatives

1987
- 1987-06-24 GB GB878714789A patent/GB8714789D0/en active Pending
1988
- 1988-05-27 EP EP88304899A patent/EP0296721B1/en not_active Expired - Lifetime
- 1988-05-27 DE DE88304899T patent/DE3881970T2/de not_active Expired - Lifetime
- 1988-05-27 ES ES88304899T patent/ES2056928T3/es not_active Expired - Lifetime
- 1988-05-30 IE IE163188A patent/IE61694B1/en not_active IP Right Cessation
- 1988-06-01 NZ NZ224868A patent/NZ224868A/en unknown
- 1988-06-03 IL IL86618A patent/IL86618A/xx not_active IP Right Cessation
- 1988-06-13 DK DK321688A patent/DK168600B1/da not_active IP Right Cessation
- 1988-06-17 ZA ZA884339A patent/ZA884339B/xx unknown
- 1988-06-22 CA CA000570135A patent/CA1340458C/en not_active Expired - Lifetime
- 1988-06-22 US US07/209,994 patent/US4866077A/en not_active Ceased
- 1988-06-23 AU AU18282/88A patent/AU615917B2/en not_active Expired
- 1988-06-23 NO NO882799A patent/NO174051C/no not_active IP Right Cessation
- 1988-06-23 FI FI883064A patent/FI93356C/fi active IP Right Grant
- 1988-06-24 PT PT87820A patent/PT87820B/pt not_active IP Right Cessation
- 1988-06-24 JP JP63155095A patent/JP2703268B2/ja not_active Expired - Lifetime
1989
- 1989-04-26 US US07/343,848 patent/US4925858A/en not_active Expired - Lifetime
1994
- 1994-08-18 HK HK84194A patent/HK84194A/en not_active IP Right Cessation
1995
- 1995-03-08 HU HU95P/P00089P patent/HU210809A9/hu unknown
1996
- 1996-05-13 US US08/648,240 patent/USRE36374E/en not_active Expired - Lifetime
1997
- 1997-05-07 BR BR1100658-7A patent/BR1100658A/pt active IP Right Grant

Also Published As

Publication number	Publication date
ZA884339B (en)	1989-05-30
IE61694B1 (en)	1994-11-16
EP0296721A3 (en)	1990-04-25
BR1100658A (pt)	1999-08-31
IE881631L (en)	1988-12-24
HK84194A (en)	1994-08-26
ES2056928T3 (es)	1994-10-16
GB8714789D0 (en)	1987-07-29
FI93356C (fi)	1995-03-27
JP2703268B2 (ja)	1998-01-26
USRE36374E (en)	1999-11-02
FI883064A7 (fi)	1988-12-25
DK321688D0 (da)	1988-06-13
DE3881970T2 (de)	1993-11-11
NZ224868A (en)	1990-07-26
US4925858A (en)	1990-05-15
DK168600B1 (da)	1994-05-02
FI883064A0 (fi)	1988-06-23
DE3881970D1 (de)	1993-07-29
EP0296721B1 (en)	1993-06-23
NO882799D0 (no)	1988-06-23
US4866077A (en)	1989-09-12
EP0296721A2 (en)	1988-12-28
FI93356B (fi)	1994-12-15
DK321688A (da)	1988-12-25
NO174051B (no)	1993-11-29
AU1828288A (en)	1989-01-05
AU615917B2 (en)	1991-10-17
CA1340458C (en)	1999-03-23
IL86618A0 (en)	1988-11-30
IL86618A (en)	1992-07-15
PT87820B (pt)	1992-10-30
NO174051C (no)	1994-03-09
PT87820A (pt)	1989-05-31
JPS6422869A (en)	1989-01-25
HU210809A9 (en)	1995-08-28

Publication	Publication Date	Title
NO882799D0 (no)	1988-06-23	Heterocykliske forbindelser.
NO893304D0 (no)	1989-08-17	Heterocykliske forbindelser.
NL970016I1 (nl)	1997-06-02	Heterocyclische verbindingen.
FI921560L (fi)	1992-04-08	Heterosykliska foereningar.
FI893381A7 (fi)	1990-01-13	Heterocykliska foereningar.
FI871632A0 (fi)	1987-04-14	Heterocykliska karboxamider.
NO880809D0 (no)	1988-02-24	Antihyperkloresterolemiske tetrazolforbindelser.
NO883613L (no)	1989-02-16	Heterocykliske forbindelser.
FI864190A7 (fi)	1987-04-18	Heterocykliska foereningar.
FI881018A7 (fi)	1988-09-06	Heterocykliska foereningar.
NO880553D0 (no)	1988-02-09	Heterosykliske forbindelser.
FI864052A7 (fi)	1987-04-18	Heterocykliska foereningar.
DE3884007D1 (de)	1993-10-21	Arylpiperazinylalkylenphenylheterocyclische Verbindungen.
FI860909A7 (fi)	1986-09-06	Heterocykliska foereningar.
DE3876298D1 (de)	1993-01-14	Heterozyklische pestizidverbindungen.
FI885886L (fi)	1989-06-22	Heterocykliska oxoftalazinyl -aettikssyror.
FI892038L (fi)	1989-10-30	Heterocykliska foereningar.
FI872566A7 (fi)	1987-12-10	Fusionerade heterocykliska imidazofoereningar.
FI905918A7 (fi)	1991-06-06	Heterocykliska foereningar.
FI882482A7 (fi)	1988-11-27	Heterocykliska foereningar.
FI864642L (fi)	1987-05-16	Heterocykliska foereningar.
IT8619233A0 (it)	1986-01-30	Composti eterociclici.
ATE93512T1 (de)	1993-09-15	Oximino-aether-verbindungen.
FI883600A7 (fi)	1989-02-04	Heterocykliska foereningar.
DE3878192D1 (de)	1993-03-18	N-phenyltetrahydrophthalimidverbindungen.

Legal Events

Date	Code	Title	Description
2008-08-11	MK1K	Patent expired